ASHP advocates and supports the professional practice of pharmacists in hospitals, health systems, ambulatory care clinics, and other settings spanning the full spectrum of medication use. The ASHP Midyear 2024 Clinical Meeting & Exhibition convenes in New Orleans, Louisiana.
What you can expect at this year’s conference
Clinical Meeting & Exhibition Set to Open in New Orleans
The American Society of Health-System Pharmacists (ASHP) Midyear 2024 Clinical Meeting & Exhibition takes place from Sunday, December 8, 2024, to Thursday, December 12, 2024, in New Orleans, Louisiana. The gathering features programming in several areas beyond the leading clinical topics of interest. More than 20,000 pharmacy professionals will convene to exchange expertise, ideas, and innovation. Read more.
Dr. Sanjay Gupta to Headline Opening Session
Multiple Emmy Award–winning chief medical correspondent and host of CNN’s podcast Chasing Life, Dr. Sanjay Gupta, will highlight the American Society of Health-System Pharmacists Midyear 2024 Clinical Meeting & Exhibition Opening Session on Monday, December 9. Dr. Gupta has spent the past 2 decades covering some of the most important health stories and brings a seasoned and experienced perspective to audiences navigating modern healthcare. Read more.
ASHP 2024 Midyear Schedule at a Glance
Click here for an overview of key events taking place during the ASHP Midyear 2024 Clinical Meeting & Exhibition, which will convene in New Orleans, Louisiana, at the Ernest N. Morial Convention Center. Attendees can choose from more than 175 hours of education sessions, networking opportunities, residency showcases, posters and roundtables, special programming, world-class speakers, and more.
Meeting Delves Into Digital Health and Informatics
Advances in data utilization and digital health technologies are rapidly changing pharmacy practice, healthcare delivery, and the patient experience. Pharmacy practitioners and pharmacy technicians are called to evolve and advance their practice to meet the new demands of a digital landscape. The ASHP Midyear 2024 Clinical Meeting & Exhibition schedule offers sessions that are focused on unique ways to address various aspects of digital health and artificial intelligence. Read more.
Post Conference Wrap Up
ASHP President Presides Over Opening Session, Awards
ASHP President Leigh A. Briscoe-Dwyer, PharmD, BSPharm, BCPS, FASHP, opened the ASHP Midyear 2024 Clinical Meeting and Exhibition on Monday, December 9, 2024. Dr. Briscoe- Dwyer said that this year’s meeting theme is “There Is Nothing Like It,” adding that the meeting is “…packed with hundreds of educational activities, career-advancing prospects, and plenty of chances to network with pharmacy peers and innovators.” Read more.
Implementing CGM Benefits the Patient
In an ASHP Midyear 2024 Clinical Meeting & Exhibition Management Case Study titled “Transforming Diabetes Care with Continuous Glucose Monitoring: Addressing Challenges in Implementation & Uptake,” Kevin Cowart, PharmD, and Nicholas W. Carris, PharmD, explored patients with type 2 diabetes who are likely to benefit from continuous glucose monitoring (CGM), as well as how to implement CGM in a primary care clinic. Read more.
Surveying the State of Health-System Pharmacy
In an ASHP Midyear 2024 Clinical Meeting & Exhibition Management Case Study titled “ASHP 2024 National Survey: A Conversation About the State of Health-System Pharmacy Practice,” Michael Ganio, PharmD, and colleagues summarized trends in hospital pharmacy practice from the 2024 ASHP National Survey of Hospital Pharmacy Practice. The presenters also identified gaps in the National Survey and Practice Advancement Initiative 2030 trends. Read more.
Myhibbin FDA Approved for Organ Rejection Prophylaxis
On May 6, 2024, Azurity Pharmaceuticals announced that the FDA approved Myhibbin (mycophenolate mofetil oral suspension), the only ready-to-use mycophenolate mofetil oral suspension. Mycophenolate mofetil is an antimetabolite immunosuppressant that is used to protect a donated organ from being rejected from the body’s immune response. Read more.
Transitioning Care for Special Patient Populations
The ASHP Midyear 2024 Clinical Meeting & Exhibition Management educational session “Big Easy Approach to Transitions of Care for Special Patient Populations,” presented by Donna Leang, PharmD, MHDS, BCPS, FCSHP, and Lydia E. Noh, PharmD, BCPS, identified specific groups that benefit from pharmacy-led care transition. In addition, the presenters examined activities to help reduce readmission rates, focusing on tools to implement and expand transition programs. Read more.
Infectious Complications in Organ Transplant Patients on Biologics
In an ASHP Midyear 2024 Clinical Meeting & Exhibition Management session titled “Anticipating the Aftermath: Infectious Complications Associated with Biologic Immunomodulators in the Solid Organ Transplant Population,” Kellie J. Goodlet, PharmD, BCIDP, BCPS, BCTXP, covered the selection of biologic therapies based on the immune target while evaluating a patient’s risk for infection. Dr. Goodlet also discussed the complementary pathway, among other transplant topics. Read more.
Pharmacist Recommendation Video
In a Pharmacist Recommendation Video, clinical pharmacists Tammie Lee Demler and Amanda Yee discuss a recently approved, ready-to-use oral suspension of mycophenolate mofetil (Myhibbin) for solid organ transplant patients. This antimetabolite immunosuppressant is indicated for prophylaxis of organ rejection in adult and pediatric patients aged 3 months and older receiving allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressants. Read more.
